Already have an account? Sign In
Vertos Medical, founded in 2005 and headquartered in Aliso Viejo, California, is a medical device company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS). The company's flagship technology, Mild, offers a guided therapeutic LSS treatment that requires no general anesthesia, implants, or stitches. Since its inception, Vertos Medical has raised a total of $172.02 million in funding, demonstrating investor confidence in its innovative approach to spinal care.
As a private company, Vertos Medical has been focused on developing and commercializing its medical technologies. While there is interest in potential investment opportunities, we have not found any concrete news or reports regarding Vertos Medical's IPO prospects at this time. The company's future plans for going public remain unclear, and it's important to note that many factors can influence a company's decision to pursue an IPO.
Investors interested in the medical device sector and companies addressing spinal health issues may want to keep an eye on Vertos Medical's progress. However, as with any potential investment, it's crucial to conduct thorough research and consider various factors before making any financial decisions. At present, there is no publicly available information about Vertos Medical stock or how to buy Vertos Medical shares directly.
Already have an account? Sign In
While Vertos Medical's IPO prospects remain uncertain, investors interested in innovative medical technology companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the healthcare and medical device sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging medical technology firms before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.